2022³â ´ëÇÑ°ñ¹ÝÅëÇÐȸ Á¦10Â÷ Çмú´ëȸ ¹× ¿¬¼ö°Á : 2022-04-10±³À°ÀÏÀÚ : 2022-04-10
±³À°Àå¼Ò : ¼ÛµµÄÁº¥½Ã¾Æ ÇÁ¸®¹Ì¾î º¼·ë AȦ
±³À°ÁÖÁ¦ :
2022³â ´ëÇÑ°ñ¹ÝÅëÇÐȸ Á¦10Â÷ Çмú´ëȸ ¹× ¿¬¼ö°Á ÁÖÃÖ±â°ü : ´ëÇÑÆó°æÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ°ñ¹ÝÅëÇÐȸ
´ã´çÀÚ : ±è°æ¹Î
¿¬¶ôó : 070-3390-2053
À̸ÞÀÏ :
cpp2011@nate.com ±³À°Á¾·ù : »êºÎÀΰú¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, ÀÇÇб³À°, ±âŸ
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ÀÎõ±¤¿ª½Ã±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í - ȸ¿ø °¡ÀÔ(Àü°øÀÇ, Àü¹®ÀÇ) : 2¸¸¿ø - ȸ¿ø ¹Ì°¡ÀÔ(Àü°øÀÇ, Àü¹®ÀÇ): 5¸¸¿ø - °£È£»ç, ¿¬±¸¿ø, ÀϹÝÀÎ: 2¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 09:00~09:15 Definition and Etiology overview Á¶¹®°æ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 09:15~09:30 Advnaces in Nociceptive and neuropathic pain ¼ÕÁÖÇõ(¾ÆÁÖÀÇ´ë)
Åä·Ð 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 09:30~09:35 Q&A ()
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 09:35~09:50 Initial evaluation and multidisplinary approach ±èÅÂÇö(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 09:50~10:05 Update of Guidelines ¹Î°æÁø(°í·ÁÀÇ´ë)
Åä·Ð 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 10:05~10:10 Q&A ()
ÈÞ½Ä 04-10 10:10~10:25 Break time ()
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 10:25~10:40 Pharmacologic intervention ÀÌÀºÁö(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 10:40~10:55 Non-surgical intervention È«´ë±â(°æºÏÀÇ´ë)
Åä·Ð 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 10:55~11:00 Q&A ()
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 11:00~11:15 Pathophysiology and Etiology ÀÌ»óÈÆ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 11:15~11:30 Pharmacological intervention ÀÌÀ¯¿µ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 11:30~11:45 Non-pharmacological intervention ±è±âÇü(ºÎ»êÀÇ´ë)
Åä·Ð 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 11:45~11:50 Q&A ()
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 11:50~12:05 ¾Ð³ë¹Ùºñ½ºÄñÀÇ Ç×¾ÏÈÇпä¹ý ±è¸í¼±(°¡Å縯ÀÇ´ë)
½Ä»ç 04-10 12:05~12:50 ½Ä»ç ()
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 12:50~13:05 Neurogenic inflammation and endometriosis Àü½ÂÁÖ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 13:05~13:20 HIFU for chronic pain ±è¿µ¼±(¹ÎÆ®º´¿ø)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 13:20~13:35 Vaginal microbiome and vulvodynia ÀÌ»ç¶ó(¿ï»êÀÇ´ë)
Åä·Ð 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 13:35~13:40 Q&A ()
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 13:40~13:55 CPP caused by pelvic varicosity: overview and management È«Á¤¾Æ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 13:55~14:10 CPP after surgery: overview, prevention and mangement ¹Ú Çö(Â÷ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 14:10~14:25 Role of laparoscopy in CPP ¹Ú¼öÁø(¼¿ïÀÇ´ë)
Åä·Ð 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 14:25~14:30 Q&A ()
ÈÞ½Ä 04-10 14:30~14:50 Break time ()
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 14:50~15:05 Prevalence and biological science ¼Û¼ö¿¬(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 15:05~15:20 Etiology and multidisplinary examination ÀÓº¸¹è(Â÷ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 15:20~15:35 Management of Vulvodynia Ȳ±Ô¸®(º¸¶ó¸Åº´¿ø)
Åä·Ð 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 15:35~15:40 Q&A ()
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 15:40~15:55 Fibromyalgia and CPP ±èÇý°æ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 15:55~16:10 Evidence based Hormone therapy ³²±ÃÁ¤(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 16:10~16:25 CPP in adolescent ±èÈñ¿¬(¿¬¼¼ÀÇ´ë)
Åä·Ð 04-10 ÇÁ¸®¹Ì¾îº¼·ë AȦ 16:25~16:30 Q&A ()